New York State Common Retirement Fund Icosavax, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$5.95 - $15.79 $22,889 - $60,744	3,847 Added 34.93%	14,862 $234,000
Q3 2023 Nov 07, 2023	BUY	$7.22 - $10.05 $830 - $1,155	115 Added 1.06%	11,015 $85,000
Q2 2023 Aug 07, 2023	SELL	$4.89 - $10.57 $12,332 - $26,657	-2,522 Reduced 18.79%	10,900 $108,000
Q4 2022 Jan 30, 2023	BUY	$2.32 - $10.97 $11,600 - $54,850	5,000 Added 59.37%	13,422 $107,000
Q3 2022 Nov 08, 2022	BUY	$3.09 - $9.21 $126 - $377	41 Added 0.49%	8,422 $27,000
Q2 2022 Aug 04, 2022	SELL	$5.7 - $10.33 $72,213 - $130,870	-12,669 Reduced 60.19%	8,381 $48,000
Q1 2022 May 05, 2022	BUY	$4.41 - $22.5 $56,051 - $285,975	12,710 Added 152.4%	21,050 $148,000
Q4 2021 Feb 02, 2022	BUY	$21.07 - $34.98 $47,196 - $78,355	2,240 Added 36.72%	8,340 $191,000
Q3 2021 Nov 02, 2021	BUY	$24.85 - $40.25 $151,585 - $245,525	6,100 New	6,100 $180,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.